Tools

LEADER 01911nam 2200469 i 4500

001 on1033691730;

003 OCoLC;

005 20180503134057.0;

006 m o d f ;

007 cr |||||||||||;

008 180503s2018 dcu ob f000 0 eng c;

035 a| (Sirsi) o1033691730;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0546-D (online);

086 0 a| GA 1.13:GAO-18-292;

088 a| GAO-18-292;

110 1 a| United States.b| Government Accountability Office,e| author.=| ^A580995;

245 10 a| Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts :b| report to congressional requesters.;

246 30 a| Information on Mifeprex labeling and ongoing monitoring efforts;

246 17 a| Revised Mifeprex labeling;

264 1 a| [Washington, D.C.] :b| United States Government Accountability Office,c| 2018.;

300 a| 1 online resource (ii, 29 pages);

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

500 a| "March 2018.";

500 a| "GAO-18-292.";

500 a| CRDP Program record.;

504 a| Includes bibliographical references.;

588 a| Description based on online resource, PDF version; title from cover (GAO, viewed April 23, 2018).;

650 0 a| Mifepristonez| United Statesx| Testing.=| ^A809027;

650 0 a| Drugsz| United Statesx| Testing.=| ^A1001107;

856 40 u| https://purl.fdlp.gov/GPO/gpo91159;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 4870504;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 4870504-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 6/8/2018x| EDOCUMENTz| JERESOURCE;

Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts : report to congressional requesters.

Author/creator	United States
Format	Electronic
Publication	[Washington, D.C.] : United States Government Accountability Office, 2018.
Description	1 online resource (ii, 29 pages)
Supplemental Content	https://purl.fdlp.gov/GPO/gpo91159
Subjects	United States. Food and Drug Administration--Rules and practice. --Evaluation. Mifepristone--United States. --Testing. Drugs--Labeling. --Standards. --United States. Drugs--United States. --Testing.

Portion of title	Information on Mifeprex labeling and ongoing monitoring efforts
Running title	Revised Mifeprex labeling
General note	"March 2018."
General note	"GAO-18-292."
General note	CRDP Program record.
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource, PDF version; title from cover (GAO, viewed April 23, 2018).
Technical rpt number	GAO-18-292
GPO item number	0546-D (online)
Govt. docs number	GA 1.13:GAO-18-292

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Food and Drug Administration: information on Mifeprex labeling changes and ongoing monitoring efforts : report to congressional requesters.

Click here for more information about this title

Availability